Prostate Cancer and the Hypofractionation Hypothesis

被引：26

作者：

Lee, W. Robert ^{[1
]}

机构：

[1] Duke Univ, Sch Med, Durham, NC 27708 USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 31期

关键词：

RADIATION-THERAPY; RADIOTHERAPY; FRACTION; TRIAL; GY;

D O I：

10.1200/JCO.2013.52.4942

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：3849 / 3851

页数：3

共 50 条

[31] Leave No Cancer Behind: The Conformal Hypofractionation Era and Head and Neck Cancer
Lester, Scott C.
Moon, Dominic H.
Patel, Samir H.
Awan, Musaddiq J.
Bakst, Richard L.
[J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 118 (01): : 165 - 168
[32] Hypofractionation in Locally Advanced Breast Cancer: "Flash" Scheme
Padilha, Marisa
Goncalves, Sara
Fardilha, Carlos
Melo, Gilberto
Miranda, Cristina
Alves, Paula
[J]. ACTA MEDICA PORTUGUESA, 2013, 26 (02): : 98 - 101
[33] Moderate hypofractionation and simultaneous integrated boost with volumetric modulated arc therapy (RapidArc) for prostate cancer Report of feasibility and acute toxicity
Alongi, F.
Fogliata, A.
Navarria, P.
Tozzi, A.
Mancosu, P.
Lobefalo, F.
Reggiori, G.
Clivio, A.
Cozzi, L.
Scorsetti, M.
[J]. STRAHLENTHERAPIE UND ONKOLOGIE, 2012, 188 (11) : 990 - 996
[34] Moderate Hypofractionation with Simultaneous Integrated Boost in Prostate Cancer: Long-term Results of a Phase I-II Study
Di Muzio, N. G.
Fodor, A.
Chiorda, B. Noris
Broggi, S.
Mangili, P.
Valdagni, R.
Dell'Oca, I.
Pasetti, M.
Deantoni, C. L.
Chiara, A.
Berardi, G.
Briganti, A.
Calandrino, R.
Cozzarini, C.
Fiorino, C.
[J]. CLINICAL ONCOLOGY, 2016, 28 (08) : 490 - 500
[35] Hypofractionation with VMAT versus 3DCRT in Post-operative Patients with Prostate Cancer
Alongi, Filippo
Cozzi, Luca
Fogliata, Antonella
Iftode, Cristina
Comito, Tiziana
Clivio, Alessandro
Villa, Elisa
Lobefalo, Francesca
Navarria, Piera
Reggiori, Giacomo
Mancosu, Pietro
Clerici, Elena
Tomatis, Stefano
Taverna, Gianluigi
Graziotti, Pierpaolo
Scorsetti, Marta
[J]. ANTICANCER RESEARCH, 2013, 33 (10) : 4537 - 4543
[36] Updated Results and Patterns of Failure in a Randomized Hypofractionation Trial for High-risk Prostate Cancer
Arcangeli, Stefano
Strigari, Lidia
Gomellini, Sara
Saracino, Biancamaria
Petrongari, Maria Grazia
Pinnaro, Paola
Pinzi, Valentina
Arcangeli, Giorgio
[J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (05): : 1172 - 1178
[37] Moderate hypofractionation and simultaneous integrated boost by helical tomotherapy in prostate cancer: monoinstitutional report of acute tolerability assessment with different toxicity scales
Ferrera, Giuseppe
Mortellaro, Gianluca
Mannino, Mariella
Caminiti, Giovanni
Spera, Antonio
Figlia, Vanessa
Iacoviello, Giuseppina
Di Paola, Gioacchino
Mazzola, Rosario
Lo Casto, Antonio
Alongi, Filippo
Pappalardo, Maria Pia
Lagalla, Roberto
[J]. RADIOLOGIA MEDICA, 2015, 120 (12): : 1170 - 1176
[38] Simultaneous integrated boost (SIB) to dominant intra-prostatic lesions during extreme hypofractionation for prostate cancer: the impact of rectal spacers
Osman, Sarah O. S.
Fairmichael, Ciaran
Whitten, Glenn
Lundy, Gavin S.
Wesselman, Rachel
Wilson, Melissa LaBonte
Hounsell, Alan R.
Prise, Kevin M.
Irvine, Denise
McGarry, Conor K.
Jain, Suneil
[J]. RADIATION ONCOLOGY, 2022, 17 (01)
[39] Stereotactic body radiotherapy for prostate cancer: A preliminary report
Lee, Yun Hee
Son, Seok Hyun
Yoon, Sei Chul
Yu, Mina
Choi, Byung Ock
Kim, Yeon Sil
Jang, Hong Seok
Lee, Sang Nam
Jang, Ji Sun
Hwang, Tae Kon
[J]. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2014, 10 (02) : E46 - E53
[40] Quality of life outcomes from a dose-per-fraction escalation trial of hypofractionation in prostate cancer
Brower, Jeffrey V.
Forman, Jeffrey D.
Kupelian, Patrick A.
Petereit, Daniel G.
Gondi, Vinai
Lawton, Colleen A.
Anger, Nick
Saha, Sandeep
Chappell, Rick
Ritter, Mark A.
[J]. RADIOTHERAPY AND ONCOLOGY, 2016, 118 (01) : 99 - 104

← 1 2 3 4 5 →